Currently, the preliminary diagnosis of AD is made by a combinationof laboratory and clinical criteria, which include neuropsychiatrictests, behavioral history assessments, and neuroimaging techniques.1−3 The main biological markers of AD are the detection of amyloid andpathologic tau proteins. The gene discussed is MAPT; the disease is Alzheimer disease.